These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2813630)

  • 1. [Evaluation of clinical and neurophysiological markers of depressive disorder with symptoms of peripheral and brain circulation disturbance].
    Strzyzewski W; Rajewski A; Sydor L; Zelechowska-Ruda E; Jaracz J
    Psychiatr Pol; 1989; 23(2):89-96. PubMed ID: 2813630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lipid metabolism in depressive syndromes with the symptoms of disorders of the cardiovascular and cerebrovascular systems during pharmacological treatment].
    Strzyzewski W; Szajnerman Z; Chłopocka-Woźniak M; Zelechowska-Ruda E; Jaracz J
    Psychiatr Pol; 1990; 24(6):32-40. PubMed ID: 2131481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies of neurophysiological reactivity and level of activation of the central nervous system in endogenous depression and circulatory system disturbances].
    Strzyzewski W; Jaracz J; Rajewska J; Szajnerman Z; Rozek B
    Psychiatr Pol; 1992; 26(1-2):10-7. PubMed ID: 1297988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset dysthymic disorder and major depression differ from early onset dysthymic disorder and major depression in elderly outpatients.
    Devanand DP; Adorno E; Cheng J; Burt T; Pelton GH; Roose SP; Sackeim HA
    J Affect Disord; 2004 Mar; 78(3):259-67. PubMed ID: 15013252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    Zajecka JM
    J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the treatment with tetracyclic and tricyclic antidepressants in patients with minor depressive disorders.
    Tudor S; Zaharia M
    Rom J Neurol Psychiatry; 1994; 32(3):185-98. PubMed ID: 7710969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of alprazolam and imipramine for treatment of outpatient depression.
    Overall JE; Biggs J; Jacobs M; Holden K
    J Clin Psychiatry; 1987 Jan; 48(1):15-9. PubMed ID: 3542981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care.
    King M; Sibbald B; Ward E; Bower P; Lloyd M; Gabbay M; Byford S
    Health Technol Assess; 2000; 4(19):1-83. PubMed ID: 11086269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical characteristics and treatment of atypical depression.
    Sovner RD
    J Clin Psychiatry; 1981 Jul; 42(7):285-9. PubMed ID: 7240114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
    J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression.
    Rogóz Z; Skuza G; Wójcikowski J; Daniel WA; Wróbel A; Dudek D; Zieba A
    Pol J Pharmacol; 2004; 56(6):849-55. PubMed ID: 15662100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific responses to imipramine and doxepin in psychoneurotic depressed patients with sleep disturbance.
    Finnerty RJ; Goldberg HL
    J Clin Psychiatry; 1981 Jul; 42(7):275-9. PubMed ID: 7240113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled double blind comparative study of single dose administration of imipramine pamoate and divided dose of imipramine hydrochloride in depressive illness.
    Khorana AB
    Indian J Physiol Pharmacol; 1981; 25(4):331-8. PubMed ID: 7042559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.
    Lueboonthavatchai P
    J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Features of cerebral-somatic and metabolic shifts in older patients with depressive states].
    Sinitskiĭ VN; Usherenko LS; Kryzhanovskaia LA; Zapotochnyĭ BA; Ugarova OP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(4):551-9. PubMed ID: 6730821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of postpsychotic depression to adjunctive imipramine or amitriptyline.
    Siris SG; Rifkin AE; Reardon GT
    J Clin Psychiatry; 1982 Dec; 43(12):485-6. PubMed ID: 6131064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of imipramine on the circulatory system in the course of endogenous depressive syndromes. I. Evaluation of the basic parameters of the circulatory system.
    Mrozikiewicz A; Strzyzewski
    Arch Immunol Ther Exp (Warsz); 1975; 23(6):795-801. PubMed ID: 769738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.